Current Treatment of Myasthenia Gravis
Mohammed Alhaidar, Sumayyah Abumurad, Betty Soliven, Kourosh Rezania
Abstract
Myasthenia gravis (MG) is the most extensively studied antibody-mediated disease in humans. Substantial progress has been made in the treatment of MG in the last century, resulting in a change of its natural course from a disease with poor prognosis with a high mortality rate in the early 20th century to a treatable condition with a large proportion of patients attaining very good disease control. This review summarizes the current treatment options for MG, including non-immunosuppressive and immunosuppressive treatments, as well as thymectomy and targeted immunomodulatory drugs.
Topics & Concepts
MedicineMyasthenia gravisThymectomyDiseaseIntensive care medicineImmunologyInternal medicineMyasthenia Gravis and ThymomaPeripheral Neuropathies and DisordersParkinson's Disease and Spinal Disorders